SCHEMBL19798774

SCHEMBL19798774

CCN1c2c(C)cccc2Sc2cccc(C)c21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.37
ALDH1A1 P00352 7/20 0.36
MAPT P10636 5/20 0.36
HTT P42858 4/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
CYP1A2 P05177 3/20 0.36
CYP2D6 P10635 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
NPC1 O15118 2/20 0.36
POLB P06746 2/20 0.36
RAB9A P51151 2/20 0.36
CYP3A4 P08684 2/20 0.36
S1PR2 O95136 1/20 0.36
LMNA P02545 1/20 0.36
ALPG P10696 1/20 0.36
PKM P14618 1/20 0.36
BLM P54132 1/20 0.36
BCHE P06276 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19798776 0.72 MAPT (0.34) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL19798773 0.72 BCHE (0.34) ALDH1A1HTTMEN1KMT2ACYP1A2
SCHEMBL1720092 0.71 MAOA (0.50) KDM1AMAPTMEN1KMT2ANPSR1
SCHEMBL19798777 0.71 BCHE (0.37) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL19798778 0.69 MAPT (0.34) MAPTLMNA
SCHEMBL2586864 0.69 MAOA (0.64) KDM1AALDH1A1MAPTMEN1KMT2A
SCHEMBL5435395 0.69 MEN1 (0.71) KDM1AALDH1A1MAPTHTTMEN1
SCHEMBL18610703 0.69 KDM1A (0.44) KDM1AALDH1A1MAPTHTTMEN1
SCHEMBL23308369 0.68 KDM1A (0.48) KDM1AALDH1A1MAPTHTTMEN1
SCHEMBL28242942 0.68 KDM1A (0.48) KDM1AALDH1A1MAPTHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10854911-B2 1,9,10-substituted phenothiazine derivatives with strained radical cations and use thereof UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2020-12-01 US disclosed
US-20180026297-A1 1,9,10-SUBSTITUTED PHENATHIAZINE DERIVATIVES WITH STRAINED RADICAL CATIONS AND USE THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2018-01-25 US disclosed
US-20180026297-A1 1,9,10-SUBSTITUTED PHENATHIAZINE DERIVATIVES WITH STRAINED RADICAL CATIONS AND USE THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10854911-B2 1,9,10-substituted phenothiazine derivatives with strained radical cations and use thereof SLC6A9, PEX3, PAOX KDM1A 3258/4885ALDH1A1 1145/4885MAPT 4337/4885
US-20180026297-A1 1,9,10-SUBSTITUTED PHENATHIAZINE DERIVATIVES WITH STRAINED RADICAL CATIONS AND USE THEREOF PFAS, SLC6A9, PEX3 KDM1A 2694/4885ALDH1A1 1765/4885MAPT 4553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.